Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rosalinda Arends, Xiang Guo, Paul G. Baverel, Ignacio González-García, James Xie, Nassim Morsli, Alejandro Yovine & Lorin K. Roskos. (2021) Association of circulating protein biomarkers with clinical outcomes of durvalumab in head and neck squamous cell carcinoma. OncoImmunology 10:1.
Read now
Read now
Iris Koopmans, Djoke Hendriks, Douwe F. Samplonius, Robert J. van Ginkel, Sandra Heskamp, Peter J. Wierstra, Edwin Bremer & Wijnand Helfrich. (2018) A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint. OncoImmunology 7:8.
Read now
Read now
Heng Yang, Takahiro Yamazaki, Federico Pietrocola, Heng Zhou, Laurence Zitvogel, Yuting Ma & Guido Kroemer. (2016) Improvement of immunogenic chemotherapy by STAT3 inhibition. OncoImmunology 5:2.
Read now
Read now
Matteo Santoni, Francesco Massari, Marzia Del Re, Chiara Ciccarese, Francesco Piva, Giovanni Principato, Rodolfo Montironi, Daniele Santini, Romano Danesi, Giampaolo Tortora & Stefano Cascinu. (2015) Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer. Expert Opinion on Investigational Drugs 24:6, pages 809-824.
Read now
Read now
Articles from other publishers (27)
Xiangyu Wu, Tianhang Li, Rui Jiang, Xin Yang, Hongqian Guo & Rong Yang. (2023) Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. Molecular Cancer 22:1.
Crossref
Crossref
Kohei Okuyama, Tomofumi Naruse & Souichi Yanamoto. (2023) Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Crossref
Yixiang Huang, Mingping Qian, Juhang Chu, Lei Chen, Wei Jian & Gang Wang. (2023) Identification of circRNA-miRNA-mRNA network in luminal breast cancers by integrated analysis of microarray datasets. Frontiers in Molecular Biosciences 10.
Crossref
Crossref
Vasantha Dhara, Sameep S. Shetty, José Alcides Almeida de Arruda, Tarcília Aparecida Silva, Remo Castro Russo, Neetha J. Shetty, Manasa Pidaparthi, Barbara Wollenberg, Vishal U.S. Rao & Thilak P.S. Gopinath. (2023) Decoding the influence of the immune system and immunotherapy targets on carcinomas: A hidden prism in oral cancer therapy. Disease-a-Month 69:1, pages 101353.
Crossref
Crossref
James J. Kang, Albert Ko, Sang Hoon Kil, Jon Mallen-St. Clair, Daniel Sanghoon Shin, Marilene B. Wang & Eri S. Srivatsan. (2023) EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:1, pages 188827.
Crossref
Crossref
Stefano Cavalieri, Mara Serena Serafini, Andrea Carenzo, Silvana Canevari, Deborah Lenoci, Federico Pistore, Rosalba Miceli, Stefania Vecchio, Daris Ferrari, Cecilia Moro, Andrea Sponghini, Alessia Caldara, Maria Cossu Rocca, Simona Secondino, Gabriella Moretti, Nerina Denaro, Francesco Caponigro, Emanuela Vaccher, Gaetana Rinaldi, Francesco Ferraù, Paolo Bossi, Lisa Licitra & Loris De Cecco. (2022) An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer. Cells 11:19, pages 3176.
Crossref
Crossref
Shelby M. Knoche, Alaina C. Larson, Gabrielle L. Brumfield, Steven Cate, William H. Hildebrand & Joyce C. Solheim. (2022) Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor. Immunologic Research 70:3, pages 371-391.
Crossref
Crossref
Ahmet Hazini, Kerry Fisher & Len Seymour. (2021) Deregulation of HLA-I in cancer and its central importance for immunotherapy. Journal for ImmunoTherapy of Cancer 9:8, pages e002899.
Crossref
Crossref
Sayantan Banik, Sudeshna Rakshit & Koustav Sarkar. (2021) The Role of STAT1 in T Helper Cell Differentiation during Breast Cancer Progression. Journal of Breast Cancer 24:3, pages 253.
Crossref
Crossref
Ting Li, Chao Zhang, Gang Zhao, Xinwei Zhang, Mengze Hao, Shafat Hassan, Min Zhang, Hong Zheng, Da Yang, Liang Liu, Farideh Mehraein-Ghomi, Xu Bai, Kexin Chen, Wei Zhang & Jilong Yang. (2020) IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters 477, pages 19-30.
Crossref
Crossref
Xueke Wang, Xiaoyan Shao, Linaer Gu, Ke Jiang, Sitong Wang, Jianhua Chen, Juemin Fang, Xianling Guo, Min Yuan, Ji Shi, Chan Ding, Songshu Meng & Qing Xu. (2020) Targeting STAT3 enhances NDV‐induced immunogenic cell death in prostate cancer cells. Journal of Cellular and Molecular Medicine 24:7, pages 4286-4297.
Crossref
Crossref
Diane Tseng, Liora Schultz, Drew Pardoll & Crystal Mackall. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
84
96.e5
.
Robert L. Ferris, Lisa Licitra, Jerome Fayette, Caroline Even, George BlumenscheinJrJr, Kevin J. Harrington, Joel Guigay, Everett E. Vokes, Nabil F. Saba, Robert Haddad, Shanmugasundaram Ramkumar, Jeffery Russell, Peter Brossart, Makoto Tahara, A. Dimitrios Colevas, Fernando Concha-Benavente, Mark Lynch, Li Li & Maura L. Gillison. (2019) Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use. Clinical Cancer Research 25:17, pages 5221-5230.
Crossref
Crossref
Yijun Jia, Xuefei Li, Tao Jiang, Sha Zhao, Chao Zhao, Limin Zhang, Xiaozhen Liu, Jinpeng Shi, Meng Qiao, Jiawei Luo, Sangtian Liu, Ruoshuang Han, Chunxia Su, Shengxiang Ren & Caicun Zhou. (2019) EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: Implications for combination therapies. International Journal of Cancer 145:5, pages 1432-1444.
Crossref
Crossref
Wenbo Ma, Fernando Concha-Benavente, Saskia J. A. M. Santegoets, Marij J. P. Welters, Ilina Ehsan, Robert L. Ferris & Sjoerd H. van der Burg. (2018) EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer. PLOS ONE 13:9, pages e0203402.
Crossref
Crossref
Changhe Zhang, Hong Xu, Zhenping Zhou, Ye Tian, Xiaofei Cao, Guochang Cheng & Qinghong Liu. (2018) Blocking of the EGFR‑STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma. Experimental and Therapeutic Medicine.
Crossref
Crossref
Zaima Mazorra, Lisset Chao, Anabel Lavastida, Belinda Sanchez, Mayra Ramos, Normando Iznaga & Tania Crombet. (2018) Nimotuzumab: beyond the EGFR signaling cascade inhibition. Seminars in Oncology 45:1-2, pages 18-26.
Crossref
Crossref
Greta Garrido, Ailem Rabasa, Cristina Garrido, Lisset Chao, Federico Garrido, Ángel M. García-Lora & Belinda Sánchez-Ramírez. (2017) Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab. Frontiers in Pharmacology 8.
Crossref
Crossref
Fernando Concha-Benavente & Robert L. Ferris. (2017) Reversing EGFR Mediated Immunoescape by Targeted Monoclonal Antibody Therapy. Frontiers in Pharmacology 8.
Crossref
Crossref
Jennifer D. Moy, Jessica M. Moskovitz & Robert L. Ferris. (2017) Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. European Journal of Cancer 76, pages 152-166.
Crossref
Crossref
Fernando Concha-Benavente & Robert L Ferris. (2017) Oncogenic growth factor signaling mediating tumor escape from cellular immunity. Current Opinion in Immunology 45, pages 52-59.
Crossref
Crossref
Jie-Jie Sun, Hui-Ting Yang, Guo-Juan Niu, Xiao-Wu Feng, Jiang-Feng Lan, Xiao-Fan Zhao & Jin-Xing Wang. (2016) β-Arrestin 1’s Interaction with TC45 Attenuates Stat signaling by dephosphorylating Stat to inhibit antimicrobial peptide expression. Scientific Reports 6:1.
Crossref
Crossref
Charli Dominguez, Kwong-Yok Tsang & Claudia Palena. (2016) Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies. Cell Death & Disease 7:9, pages e2380-e2380.
Crossref
Crossref
Fernando Concha-Benavente, Raghvendra Srivastava, Soldano Ferrone & Robert L. Ferris. (2016) Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells. Oral Oncology 58, pages 52-58.
Crossref
Crossref
Lorenzo Galluzzi, José Manuel Bravo-San Pedro, Oliver Kepp & Guido Kroemer. (2016) Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences 73:11-12, pages 2405-2410.
Crossref
Crossref
Sjoerd H. van der Burg, Ramon Arens, Ferry Ossendorp, Thorbald van Hall & Cornelis J. M. Melief. (2016) Vaccines for established cancer: overcoming the challenges posed by immune evasion. Nature Reviews Cancer 16:4, pages 219-233.
Crossref
Crossref
Raghvendra M. Srivastava, Sumita Trivedi, Fernando Concha-Benavente, Jie Hyun-bae, Lin Wang, Raja R. Seethala, Barton F. BranstetterIVIV, Soldano Ferrone & Robert L. Ferris. (2015) STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients. Cancer Immunology Research 3:8, pages 936-945.
Crossref
Crossref